Engineering HIV-1 Integrase for Provirus Removal
Gorica Rakleova of Sofia University in Bulgaria proposes to identify and create a library of HIV-1 integrase variants that are capable of removing virus sequences from infected cell genomes. If successful, these variants could be used as new HIV therapies.